Clinical Trial

Pharmacogenomics to Improve Supportive Care Symptoms.

Study acronym: PISCES
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To understand the clinical utility of multi-gene pharmacogenetic testing in patients receiving palliative and supportive care across palliative care settings (inpatient hospital, outpatient), specifically to calculate a drug-gene interaction ratio, based on extant prescriptions paired with an individual's pharmacogenetic results.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-25.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-07-11
Trial Details
NCT Number NCT06856122
Lead Sponsor Norfolk and Norwich University Hospitals NHS Foundation Trust
Collaborators: Manchester Centre for Genomic Medicine - St. Mary's Hospital University of Manchester
Conditions Palliative Care, Supportive Care
Enrollment 50 participants
Start Date 2025-05-09
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-14